TABLE 2. Demographic Data of Patients in Group III (Individuals With Moderate or Severe Hepatic Steatosis Who Had an METAVIR Score).
| Characteristics | Group III |
|---|---|
| Male/Female | 44/21 |
| Age, years | |
| Mean ± standard deviation (range) | 53.26 ± 10.76 (35 - 74) |
| Median | 54 |
| BMI, kg/m2 | |
| Mean ± standard deviation (range) | 27.61 ± 3.40 (21.37 - 37.83) |
| Median | 27.82 |
| AST, U/L | |
| Mean ± standard deviation (range) | 74.37 ± 70.91 (25 - 507) |
| Median | 53 |
| ALT, U/L | |
| Mean ± standard deviation (range) | 97.07 ± 91.82 (20 - 595) |
| Median | 74 |
| Histological fibrosis grade, no. of patients | |
| F0 | 7 |
| F1 | 14 |
| F2 | 9 |
| F3 | 16 |
| F4 | 19 |
Unless otherwise noted, data are expressed as numbers of patients. BMI: body mass index, AST: aspartate aminotransferase, ALT: alanine aminotransferase. Normal AST levels for female and male patients are less than 35 and 50 U/L, respectively. Normal ALT levels for female and male patients are less than 19 and 30 U/L, respectively.